St. James's Place plc
St. James's Place plc (STJPF) Financial Performance & Income Statement Overview
Explore the financials of St. James's Place plc (STJPF), including yearly and quarterly data on income, cash flow, and balance sheets.
St. James's Place plc (STJPF) Income Statement & Financial Overview
Explore comprehensive income reports for St. James's Place plc STJPF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $10.13B | $15.78B | $11.05B | $7.96B |
| Cost of Revenue | $10.13B | $14.11B | $9.56B | $6.61B |
| Gross Profit | $0.00 | $1.66B | $1.49B | $1.35B |
| Gross Profit Ratio | $0.00 | $0.11 | $0.13 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $1.10B | $1.42B | $1.008B |
| Operating Expenses | $0.00 | $1.10B | $1.38B | $970.30M |
| Total Costs & Expenses | -$9.68B | $15.21B | -$10.93B | -$7.58B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $13.30M | $20.80M | $18.60M |
| EBITDA | $472.10M | $580.60M | $21.00M | $387.10M |
| EBITDA Ratio | $0.05 | $0.04 | $0.002 | $0.05 |
| Operating Income | $452.60M | $567.30M | $23.10M | $374.20M |
| Operating Income Ratio | $0.04 | $0.04 | $0.002 | $0.05 |
| Other Income/Expenses (Net) | $19.50M | $9.70M | $31.50M | $10.80M |
| Income Before Tax | $472.10M | $577.00M | $54.60M | $385.00M |
| Income Before Tax Ratio | $0.05 | $0.04 | $0.005 | $0.05 |
| Income Tax Expense | $238.80M | $411.90M | $226.20M | $223.30M |
| Net Income | $233.30M | $165.10M | -$171.70M | $161.60M |
| Net Income Ratio | $0.02 | $0.01 | -$0.02 | $0.02 |
| EPS | $0.43 | $0.30 | -$0.31 | $0.30 |
| Diluted EPS | $0.43 | $0.30 | -$0.31 | $0.29 |
| Weighted Avg Shares Outstanding | $543.44M | $552.17M | $545.19M | $546.00M |
| Weighted Avg Shares Outstanding (Diluted) | $546.27M | $552.90M | $545.19M | $548.10M |
The company's financials show resilient growth, with revenue advancing from $7.96B in Q2 2023 to $10.13B in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to 17% in Q2 2023. Operating income hit $452.60M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $472.10M. Net income rose to $233.30M, while earnings per share reached $0.43. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan